Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

O15_EXIST_HYPERT_COMPLIC

hypertension: Persistently high systemic arterial blood pressure. Based on multiple readings (blood pressure determination), hypertension is currently defined as when systolic pressure is consistently greater than 140 mm Hg or when diastolic pressure is consistently 90 mm Hg or more.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only females	293373
2. Check conditions None	293373
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — O10 Hospital discharge: ICD-9 — 6420 Cause of death: ICD-10 — O10 Cause of death: ICD-9 — 6420 2 out of 7 registries used, show all original rules.	3239
4. Check minimum number of events None	3239
5. Include endpoints None	3239
6. Filter based on genotype QC (FinnGen only)	3239

Control definitions (FinnGen only)

Control exclude: O15_OEDEM_PROTUR_HYPERT

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF3
Parent code in ICD-10: O10-O16
Name in latin: Hypertensio prae-existens graviditatem, partum et/sive puerperium complicans

NAME	O15_EXIST_HYPERT_COMPLIC
CONTROL_EXCLUDE	O15_OEDEM_PROTUR_HYPERT
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	O10
HD_ICD_9	6420
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	O10
COD_ICD_9	6420
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pre-existing hypertension complicating pregnancy, childbirth and the puerperium based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	20952	20952	-
Only index persons	20618	20618	-
Unadjusted period prevalence (%)
Whole population	0.60	0.60	-
Only index persons	0.76	0.76	-
Median age at first event (years)
Whole population	-	32.95	-
Only index persons	-	32.90	-

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3239	3239	-
Unadjusted period prevalence (%)	1.10	1.10	-
Median age at first event (years)	33.06	33.06	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2918: Matched controls
29180

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

C07AG01

ATC

labetalol; systemic

163.4

323.0

659

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

5061.1

323.0

1045

205

Kela drug reimbursment

Chronic hypertension

11.9

323.0

978

1188

6420X

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium

+∞

323.0

520

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4503599627370496.0

323.0

2311

I10

ICD-10 Finland

Essential (primary) hypertension

8.8

323.0

1962

5525

O14.0

ICD-10 Finland

Mild to moderate pre-eclampsia

+∞

323.0

335

C09AA02

ATC

enalapril; systemic

8.6

316.3

760

1144

C08CA01

ATC

amlodipine; oral

5.5

281.8

1014

2593

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

5.2

256.7

964

2542

O10.9

ICD-10 Finland

Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium

+∞

223.9

212

C07AB02

ATC

metoprolol; systemic

5.4

201.3

695

1609

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

3.7

181.4

996

3566

C08CA05

ATC

nifedipine; systemic

9.4

178.9

392

474

O14.1

ICD-10 Finland

Severe pre-eclampsia

+∞

171.6

163

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

3.8

167.7

853

2832

O14.9

ICD-10 Finland

Pre-eclampsia, unspecified

576.7

166.9

164

C07AB07

ATC

bisoprolol; oral

3.1

159.7

1190

5259

6423A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]

+∞

158.8

151

A10BA02

ATC

metformin; oral

3.5

127.4

713

2480

C09CA01

ATC

losartan; oral

3.6

126.2

660

2173

MA2DE

NOMESCO Finland

Detailed ultrasound examination of fetus including color doppler method

3.4

120.3

677

2351

E66.01

ICD-10 Finland

Obesity due to excess calories

4.0

119.8

550

1613

O11

ICD-10 Finland

Pre-eclampsia superimposed on chronic hypertension

+∞

118.5

113

C09BA02

ATC

enalapril and diuretics; systemic

9.2

114.3

250

294

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

3.8

113.9

550

1680

C08CA13

ATC

lercanidipine; oral

5.3

108.5

359

753

C09AA05

ATC

ramipril; oral

3.9

103.3

471

1359

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

5.1

103.0

354

773

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

2.3

100.8

1485

8992

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

7.9

99.3

238

324

103

Kela drug reimbursment

Diabetes, insulin-treated

3.1

95.0

606

2261

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.1

94.8

602

2240

O16

ICD-10 Finland

Unspecified maternal hypertension

323.9

94.5

C03AA03

ATC

hydrochlorothiazide; oral

6.0

94.3

277

501

C09CA06

ATC

candesartan; oral

2.7

93.5

764

3344

O10.1

ICD-10 Finland

Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium

+∞

93.2

6424A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]

+∞

87.9

MA2AE

NOMESCO Finland

Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus

2.4

86.5

966

4990

K85

ICPC

Elevated blood pressure

3.8

84.2

389

1123

O36.5

ICD-10 Finland

Maternal care for poor fetal growth

5.0

82.7

283

610

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

80.6

460

1569

W84

ICPC

Pregnancy high risk

4.5

80.4

305

732

E66.9

ICD-10 Finland

Obesity, unspecified

5.4

78.6

253

508

C09DA01

ATC

losartan and diuretics; oral

4.6

77.3

289

682

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

3.0

76.4

492

1822

ZXD05

NOMESCO Finland

Urgent procedure

2.1

74.7

1147

6766

MA2HE

NOMESCO Finland

Detailed morfological ultrasound examination of fetus

2.2

74.2

991

5490

C08CA02

ATC

felodipine; oral

6.3

71.1

199

336

E66.8

ICD-10 Finland

Other obesity

3.6

70.7

350

1063

C09CA03

ATC

valsartan; oral

4.9

69.5

240

520

K86

ICPC

Hypertension uncomplicated

4.6

69.3

257

600

63701

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia

+∞

69.0

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

3.3

68.1

388

1312

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

6.1

65.7

187

322

SPAT1262

SPAT

Handing over of treatment supplies

2.8

64.2

456

1784

C09DA06

ATC

candesartan and diuretics; oral

4.9

64.1

224

491

T90

ICPC

Diabetes non-insulin dependent

2.8

63.0

462

1841

E66.00

ICD-10 Finland

Metabolic syndrome

4.4

54.7

211

510

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

11.4

53.5

102

Z39.2

ICD-10 Finland

Routine postpartum follow-up

2.1

53.4

738

4037

O82.0

ICD-10 Finland

Delivery by elective caesarean section

2.8

52.1

366

1410

C07AG02

ATC

carvedilol; oral

7.0

50.3

128

189

MAA00

NOMESCO Finland

Amniocentesis

3.9

49.9

217

586

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.6

49.4

181

415

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.6

49.4

235

685

O12.1

ICD-10 Finland

Gestational proteinuria

254.4

49.2

Z36.0

ICD-10 Finland

Antenatal screening for chromosomal anomalies

2.8

48.4

348

1356

O60

ICD-10 Finland

Preterm labour and delivery

3.8

48.4

220

617

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.3

47.7

496

2367

C02EA02

ATC

16.9

47.4

C02CB01

ATC

243.9

47.1

C10AA01

ATC

simvastatin; oral

2.3

47.1

508

2467

Z35.9

ICD-10 Finland

Supervision of high-risk pregnancy, unspecified

3.3

46.3

253

821

A10AE04

ATC

insulin glargine; parenteral

3.3

44.8

240

767

C07BB07

ATC

bisoprolol and thiazides; systemic

6.1

43.2

121

204

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

4.4

43.1

162

381

XMA22

NOMESCO Finland

General examination of pregnant woman

2.4

42.9

407

1848

SPAT1379

SPAT

Health check-up of pregnant person

2.1

42.6

550

2884

O80.8

ICD-10 Finland

Other single spontaneous delivery

2.9

41.9

270

980

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.4

41.6

158

376

W85

ICPC

Gestational diabetes

3.0

41.2

251

877

C09AA03

ATC

lisinopril; oral

6.3

40.5

111

182

MAC96

NOMESCO Finland

Other induction or advancement of labour

3.5

40.4

200

601

Z32.1

ICD-10 Finland

Pregnancy confirmed

2.0

40.1

575

3142

A10AE05

ATC

insulin detemir; parenteral

3.7

39.3

181

512

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.7

39.0

285

1118

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

4.3

39.0

151

366

C09DA03

ATC

valsartan and diuretics; oral

5.4

38.8

120

229

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.9

38.5

246

886

6425A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]

+∞

37.6

C10AA05

ATC

atorvastatin; oral

2.1

37.5

516

2763

C02AC05

ATC

moxonidine; oral

7.0

37.0

139

O99.4

ICD-10 Finland

Diseases of the circulatory system complicating pregnancy, childbirth and the puerperium

9.3

37.0

A10BK03

ATC

empagliflozin; oral

3.5

37.0

180

533

B01AB05

ATC

enoxaparin; parenteral

1.8

34.6

728

4535

A10BJ06

ATC

semaglutide; parenteral

4.6

34.6

123

274

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

+∞

34.4

C03CA01

ATC

furosemide; systemic

2.3

34.3

351

1643

4019X

ICD-9 Finland

Essential hypertension, Unspecified

21.6

33.5

G47.3

ICD-10 Finland

Sleep apnoea

2.0

33.0

486

2662

C09CA07

ATC

telmisartan; oral

3.4

33.0

169

521

O68.0

ICD-10 Finland

Labour and delivery complicated by fetal heart rate anomaly

2.3

32.8

316

1434

C09DA07

ATC

telmisartan and diuretics; oral

4.7

32.7

114

249

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

3.7

32.4

146

406

6424B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]

+∞

32.3

40199

ICD-8 Finland

Essential benign hypertension

39.5

31.2

O10.4

ICD-10 Finland

Pre-existing secondary hypertension complicating pregnancy, childbirth and the puerperium

316.1

30.9

6425B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]

+∞

30.3

T82

ICPC

Obesity

3.0

29.7

180

624

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.1

29.7

368

1874

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.4

29.2

145

436

MA2XE

NOMESCO Finland

Other obstetric ultrasound examination

2.0

28.3

396

2117

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

3.3

28.3

146

453

W78

ICPC

Pregnancy

1.7

27.9

668

4292

O41.0

ICD-10 Finland

Oligohydramnios

3.3

27.8

145

453

C07BB02

ATC

metoprolol and thiazides; systemic

15.1

27.8

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.3

27.8

143

443

C03DA01

ATC

spironolactone; oral

2.7

27.8

196

750

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.0

27.6

114

294

C07AB03

ATC

atenolol; systemic

4.4

27.5

102

238

A10BJ02

ATC

liraglutide; parenteral

5.1

26.6

174

C09DB01

ATC

valsartan and amlodipine; oral

6.1

26.5

122

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

4.5

26.4

220

6420A

ICD-9 Finland

+∞

26.1

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.9

25.6

162

578

C03BA11

ATC

indapamide; oral

6.6

25.4

102

E66

ICD-10 Finland

Obesity

2.6

25.3

192

766

C10AA07

ATC

rosuvastatin; oral

1.9

25.0

380

2089

160

Kela drug reimbursment

exenatide

6.1

24.6

114

MA1AE

NOMESCO Finland

Ultrasound examination of early pregnancy (before 12. postmenstrual week)

1.7

24.5

530

3285

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

24.1

355

1929

C07AB08

ATC

celiprolol; oral

10.8

24.1

O10.3

ICD-10 Finland

Pre-existing hypertensive heart and renal disease complicating pregnancy, childbirth and the puerperium

+∞

24.0

C07FB02

ATC

metoprolol and felodipine; systemic

9.6

24.0

SPAT1310

SPAT

Counselling related to known health issue

1.6

23.6

793

5544

A10BH01

ATC

sitagliptin; oral

2.8

23.4

152

553

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

23.4

1086

8196

A10BK01

ATC

dapagliflozin; oral

3.5

23.3

113

335

A12BA01

ATC

potassium chloride; oral

7.3

23.2

C09AA04

ATC

perindopril; oral

4.0

22.5

232

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

5.0

22.3

146

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.2

22.3

120

385

WX320

NOMESCO Finland

Spinalanesthesy

1.7

22.2

542

3472

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.7

22.0

160

624

Z87.5

ICD-10 Finland

Personal history of complications of pregnancy, childbirth and the puerperium

4.7

21.8

159

C08CA03

ATC

isradipine; systemic

20.2

21.7

FM1QE

NOMESCO Finland

Extensive ultrasound of fetal heart

6.5

21.6

W92

ICPC

Compl labour/ delivery livebirth

3.1

21.3

119

393

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

20.9

172

718

8811

FHL

Cesarean section

2.0

20.9

265

1356

6488A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance

3.5

20.6

282

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

20.5

796

5728

N02BE01

ATC

paracetamol; systemic, rectal

1.6

20.5

2389

21635

C07AB05

ATC

betaxolol; oral

7.7

20.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.2

20.3

108

345

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

20.1

745

5298

R5140

NOMESCO Finland

Monitoring the use of the aid

2.2

19.7

207

975

Z35.2

ICD-10 Finland

Supervision of pregnancy with other poor reproductive or obstetric history

2.9

19.7

124

443

SPAT1380

SPAT

Postpartum check-up

1.8

19.7

405

2459

SPAT1263

SPAT

Sampling

1.5

19.6

1112

8666

O61.0

ICD-10 Finland

Failed medical induction of labour

4.0

19.4

203

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

7.8

19.3

Z35

ICD-10 Finland

Supervision of high-risk pregnancy

4.3

19.3

171

O32.1

ICD-10 Finland

Maternal care for breech presentation

2.0

19.2

258

1347

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

19.2

402

2454

O12.0

ICD-10 Finland

Gestational oedema

22.7

19.0

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.8

19.0

353

2073

O10

ICD-10 Finland

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

+∞

18.8

T89

ICPC

Diabetes insulin dependent

2.7

18.6

128

484

O80.0

ICD-10 Finland

Spontaneous vertex delivery

1.4

18.6

1396

11443

H3603, E103

ICD-10 Finland

5.4

18.4

103

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

6.6

18.4

J01DA01

ATC

[U] cefalexin; systemic

1.4

18.4

1848

15978

I15.9

ICD-10 Finland

Secondary hypertension, unspecified

9.6

18.3

ACC51

NOMESCO Finland

Release of median nerve

2.0

18.2

228

1160

ZXE00

NOMESCO Finland

One hour or less

1.4

18.1

1124

8870

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

4.7

18.1

131

V230A

ICD-9 Finland

Supervision of high-risk pregnancy, Pregnancy with history of infertility

4.2

17.8

165

SPAT1196

SPAT

Monitoring of normal pregnancy

1.8

17.7

348

2080

H04AA01

ATC

glucagon; nasal, parenteral

3.1

17.6

319

C09BA03

ATC

lisinopril and diuretics; oral

7.6

17.3

A10AA02

ATC

2.9

17.3

106

374

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.6

17.2

125

486

O63.0

ICD-10 Finland

Prolonged first stage (of labour)

2.6

17.1

129

516

SPAT1197

SPAT

Extensive health check-up of expecting family

1.6

17.0

553

3794

A10AA01

ATC

2.9

16.7

102

358

6423B

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, SYNNYTYKSEN AIKANA]

+∞

16.7

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

16.6

236

1260

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

16.6

429

2772

O40

ICD-10 Finland

Polyhydramnios

3.5

16.6

228

A10BX04

ATC

[U] exenatide; parenteral

8.3

16.5

J01DB01

ATC

cefalexin; oral

1.5

16.3

2336

21313

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

16.3

884

6767

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.2

16.2

177

849

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

1.7

16.1

391

2483

C09AA01

ATC

captopril; oral

16.8

16.1

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

7.5

15.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

15.7

772

5785

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

3.0

15.5

307

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.0

15.4

302

SPAT1153

SPAT

Removal of sutures

1.5

15.2

631

4561

A10BB12

ATC

glimepiride; oral

3.8

15.2

171

C07AB12

ATC

nebivolol; oral

3.2

15.1

256

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

4.4

14.9

121

C02EA03

ATC

21.1

14.6

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

4.4

14.5

120

O20.0

ICD-10 Finland

Threatened abortion

2.2

14.4

156

746

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

14.4

319

1975

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

14.3

307

1881

C08CA10

ATC

nilvadipine; oral

6.3

14.2

J01FA06

ATC

roxithromycin; oral

1.4

14.0

1137

9285

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

14.0

727

5484

G03DB01

ATC

dydrogesterone; oral

1.5

13.9

614

4483

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

5.7

13.9

Z35.0

ICD-10 Finland

Supervision of pregnancy with history of infertility

2.1

13.9

156

757

C08DB01

ATC

diltiazem; oral

4.3

13.9

121

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

13.8

428

2889

SPAT1097

SPAT

Recording of ECG

1.8

13.8

243

1402

LGA10

NOMESCO Finland

Sterilisation by destruction or division of Fallopian tubes

3.2

13.7

220

63700

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)

+∞

13.5

H3600, E103

ICD-10 Finland

4.0

13.4

135

J01AA02

ATC

doxycycline; systemic

1.4

13.4

2184

19884

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.6

13.2

325

2065

WX110

NOMESCO Finland

Local anesthesy

1.4

13.2

1985

17803

O36.3

ICD-10 Finland

Maternal care for signs of fetal hypoxia

4.5

13.2

104

XCK10

NOMESCO Finland

Photography of fundus of eye

2.0

12.9

159

805

C10AX09

ATC

ezetimibe; oral

2.3

12.8

120

540

O03.9

ICD-10 Finland

Spontaneous abortion, Complete or unspecified, without complication

1.8

12.6

224

1293

A10BG03

ATC

pioglitazone; oral

5.2

12.5

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.6

12.5

341

2226

6462A

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension

+∞

12.5

SPAT1301

SPAT

No procedures

1.4

12.5

675

5114

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

6.7

12.5

ZXD00

NOMESCO Finland

Emergency procedure

2.3

12.4

114

505

SPAT1325

SPAT

Vaccination

1.4

12.4

640

4806

O82.11

ICD-10 Finland

Childbirth with an emergency caesarean section in an emergency

3.0

12.4

247

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.8

12.2

295

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

12.2

164

860

J01CA04

ATC

amoxicillin; systemic

1.4

12.1

2373

22029

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

12.1

506

3646

A10BD07

ATC

metformin and sitagliptin; systemic

3.1

12.1

218

WX290

NOMESCO Finland

Other blockade of nerve

1.3

12.0

1417

12155

N02AX02

ATC

tramadol; systemic, rectal

1.4

11.9

909

7299

6480A

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Diabetes mellitus

4.1

11.9

111

6565B

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,SYNN AIK]

7.9

11.8

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

11.8

265

1644

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

11.7

1591

13911

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.9

11.7

A10BJ01

ATC

exenatide; parenteral

7.4

11.7

B01AB04

ATC

dalteparin; parenteral

2.3

11.7

106

467

O99.80

ICD-10 Finland

The fear of childbirth

1.7

11.5

235

1417

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

11.5

845

6735

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

11.5

152

791

S18

ICPC

Laceration/cut

1.4

11.4

806

6381

O26.82

ICD-10 Finland

Exhaustion and fatigue pregnancy-related

2.5

11.4

372

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.7

11.2

BEF00

NOMESCO Finland

Continuous subcutaneous glucose monitoring

4.4

11.2

H3601, E103

ICD-10 Finland

4.1

11.2

103

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

11.1

959

7831

E66.0

ICD-10 Finland

Obesity due to excess calories

4.9

11.1

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.6

11.1

315

2078

CKC10

NOMESCO Finland

Local photocoagulation of retina

4.3

11.0

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.5

11.0

145

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

11.0

1181

9956

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.0

11.0

105

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

10.9

1739

15477

C02EA01

ATC

28.1

10.7

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

10.7

1188

10045

63704

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis

+∞

10.4

6427A

ICD-9 Finland

Hypertension complicating pregnancy, childbirth and the puerperium, Pre-eclampsia or eclampsia superimposed on pre-existing hypertension[PRAE-ECL SEU ECL CUM HYPERT ART,ENNEN SYNNYTYSTÄ]

+∞

10.4

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

10.4

1413

12269

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

3.3

10.4

152

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.0

10.3

186

MBA03

NOMESCO Finland

Curettage of uterus after delivery or abortion

1.8

10.3

171

967

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

10.2

943

7755

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

10.2

222

1365

O02.1

ICD-10 Finland

Missed abortion

1.6

10.2

274

1784

K25

ICPC

Fear of hypertension

2.8

10.2

233

C09BA04

ATC

perindopril and diuretics; systemic

5.0

10.1

C01DA14

ATC

isosorbide mononitrate; oral

2.8

10.1

226

O36.0

ICD-10 Finland

Maternal care for rhesus isoimmunization

7.9

10.1

H01

ICPC

Ear pain/earache

1.6

10.1

291

1926

CKC12

NOMESCO Finland

Photocoagulation of retina

2.4

10.1

376

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

2.0

10.0

119

594

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.3

10.0

146

C09CA08

ATC

olmesartan medoxomil; oral

3.7

10.0

115

O20.9

ICD-10 Finland

Haemorrhage in early pregnancy, unspecified

1.9

9.9

140

750

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

9.9

835

6770

R80

ICD-10 Finland

Isolated proteinuria

6.3

9.8

C07AA03

ATC

pindolol; systemic

8.1

9.8

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.1

9.8

O68.8

ICD-10 Finland

Labour and delivery complicated by other evidence of fetal stress

2.8

9.8

210

6468B

ICD-9 Finland

Other complications of pregnancy, not elsewhere classified, Other specified complications of pregnancy[RASKAUDENAIKAINEN LIIKALIHAVUUS]

20.1

9.8

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

9.7

104

499

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

9.7

410

2949

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

3.3

9.7

139

A10AE06

ATC

insulin degludec; parenteral

2.5

9.7

303

N18.8

ICD-10 Finland

Other chronic renal failure

4.7

9.6

A10BX09

ATC

[U] dapagliflozin; oral

6.4

9.5

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

9.5

1058

8902

SPAT1312

SPAT

General health counselling

1.3

9.5

757

6076

R51.80

ICD-10 Finland

Headache

1.4

9.5

439

3218

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.6

9.4

111

B01AC04

ATC

clopidogrel; oral

2.1

9.3

466

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.6

9.3

278

1854

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

9.3

334

2323

6565A

ICD-9 Finland

Other foetal and placental problems affecting management of mother, Poor foetal growth[SIKIÖN HIDASTUNUT INTRAUTERIININ KASVU,RASK AIK]

5.2

9.2

C09BA05

ATC

ramipril and diuretics; oral

4.7

9.2

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.7

9.2

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

3.7

9.2

103

Z30.2

ICD-10 Finland

Sterilization

1.4

9.1

441

3258

MAB10

NOMESCO Finland

External version

3.1

9.1

157

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

2.1

9.1

104

515

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.6

9.1

211

1322

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.0

9.0

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

2.7

9.0

232

N03AX12

ATC

gabapentin; oral

1.5

9.0

347

2448

Z94.0

ICD-10 Finland

Kidney transplant status

4.9

9.0

SPAT1240

SPAT

Therapeutic discussion

1.5

8.9

328

2296

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.0

8.8

104

520

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.7

8.8

229

B02AA02

ATC

tranexamic acid; systemic

1.4

8.8

565

4380

QBJ30

NOMESCO Finland

Correction of abdominal apron

3.1

8.8

145

MBA00

NOMESCO Finland

Vacuum aspiration from uterus after delivery or abortion

1.9

8.8

124

665

J01FF01

ATC

clindamycin; systemic

1.3

8.7

645

5110

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

8.7

206

1296

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.9

8.7

128

697

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

8.7

386

MAC01

NOMESCO Finland

Rupture of aminiotic membrane for induction of labor

2.3

8.7

345

SPAT1200

SPAT

Guidance for breast-feeding and breast care

2.0

8.7

113

586

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

2.9

8.7

173

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

8.6

424

3137

C09CA02

ATC

eprosartan; oral

6.6

8.6

O36.4

ICD-10 Finland

Maternal care for intrauterine death

3.5

8.6

109

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.3

8.6

328

207

Kela drug reimbursment

Chronic arrhythmias

2.4

8.6

309

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

8.6

177

1074

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

8.6

433

3220

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

6.9

8.5

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

8.5

183

1122

I15.0

ICD-10 Finland

Renovascular hypertension

27.6

8.5

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.6

8.4

W81

ICPC

Toxaemia of pregnancy

90.3

8.4

SPAT1189

SPAT

Other ultrasound examination during pregnancy

1.9

8.4

125

681

Z35.5

ICD-10 Finland

Supervision of elderly primigravida

3.4

8.4

117

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.0

8.4

150

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

8.3

1453

12870

63710

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia

+∞

8.3

O10.2

ICD-10 Finland

Pre-existing hypertensive renal disease complicating pregnancy, childbirth and the puerperium

+∞

8.3

O12.2

ICD-10 Finland

Gestational oedema with proteinuria

+∞

8.3

H02AB06

ATC

prednisolone; systemic

1.3

8.3

1118

9600

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

3.2

8.3

129

O41.1

ICD-10 Finland

Infection of amniotic sac and membranes

2.8

8.3

186

O02.0

ICD-10 Finland

Blighted ovum and nonhydatidiform mole

1.7

8.3

157

930

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.6

8.3

238

K04.0

ICD-10 Finland

Pulpitis

1.5

8.2

310

2177

A10BX07

ATC

[U] liraglutide; parenteral

4.4

8.2

O72.2

ICD-10 Finland

Delayed and secondary postpartum haemorrhage

2.3

8.2

337

AA1AD

NOMESCO Finland

CT of head and brain

1.5

8.2

335

2395

A46

ICD-10 Finland

Erysipelas

1.7

8.1

179

1106

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.7

8.0

LGA20

NOMESCO Finland

Sterilisation by constriction of Fallopian tubes

2.4

8.0

264

CK2S4

SPAT

5.5

8.0

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.4

8.0

276

R03DC03

ATC

montelukast; oral

1.4

7.9

467

3567

H3603, E113

ICD-10 Finland

7.8

7.9

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.5

7.8

292

2046

6440B

ICD-9 Finland

Early or threatened labour, Threatened premature labour[PARTUS PRAEMATURUS]

2.4

7.8

262

AN1

Coronary angiography

2.3

7.7

305

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

7.7

143

844

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

7.7

192

1229

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

7.6

256

1753

R01AD09

ATC

mometasone; nasal

1.2

7.6

1380

12224

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.7

7.6

183

H36.01

ICD-10 Finland

Diabetic maculopathy

4.0

7.6

SPAT1283

SPAT

Restricted health certificate

1.3

7.5

681

5544

O34.1

ICD-10 Finland

Maternal care for tumour of corpus uteri

3.4

7.5

101

Z39.1

ICD-10 Finland

Care and examination of lactating mother

2.0

7.5

435

A11CC03

ATC

alfacalcidol; systemic

3.2

7.5

112

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

7.5

657

5323

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

7.5

746

6151

A10BH05

ATC

linagliptin; oral

3.0

7.4

135

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

7.4

543

4284

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

7.4

428

3257

SPAT1260

SPAT

Consultation of another employee

1.4

7.4

358

2640

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.0

7.4

429

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

0.6

7.4

1403

FM1NE

NOMESCO Finland

Ultrasound examination of fetal heart

4.1

7.4

63702

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema

+∞

7.3

O14

ICD-10 Finland

Pre-eclampsia

+∞

7.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

7.3

411

3114

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.1

7.2

393

K02.1

ICD-10 Finland

Caries of dentine

1.2

7.1

1645

14923

H03AA01

ATC

levothyroxine sodium; systemic

1.3

7.1

622

5030

A10AA03

ATC

4.0

7.1

G02CB01

ATC

bromocriptine; systemic

1.9

7.1

476

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.5

7.0

199

R03AC02

ATC

salbutamol; inhalant

1.2

7.0

1457

13059

G03FB08

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, sequential prep.)

0.6

7.0

1361

A02BC01

ATC

omeprazole; systemic

1.3

7.0

565

4518

MWE00

NOMESCO Finland

Reoperation for deep haemorrhage in obstetric surgery

7.0

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

4.0

7.0

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

7.0

269

1902

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

6.9

1473

13228

137

Kela drug reimbursment

Uraemia requiring dialysis

5.8

6.9

E87.6

ICD-10 Finland

Hypokalaemia

2.4

6.9

221

R09

ICPC

Sinus symptom/complaint

1.5

6.9

251

1751

SPAT1316

SPAT

Extensive health check-up of children and adolescents

1.8

6.9

109

613

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

6.9

276

1965

J01FA10

ATC

azithromycin; systemic

1.2

6.8

1749

16007

H3602, E103

ICD-10 Finland

8.3

6.8

WZC30

NOMESCO Finland

Teaching

1.5

6.8

247

1723

TK820

NOMESCO Finland

Peritoneal dialysis

9.3

6.8

O99.0

ICD-10 Finland

Anaemia complicating pregnancy, childbirth and the puerperium

2.5

6.8

198

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

6.8

978

8415

O61.8

ICD-10 Finland

Other failed induction of labour

6.1

6.8

ZXA10

NOMESCO Finland

Bilateral

1.4

6.7

337

2499

ZXA00

NOMESCO Finland

Right side

1.3

6.7

466

3644

O35.8

ICD-10 Finland

Maternal care for other (suspected) fetal abnormality and damage

2.0

6.7

425

SPAT1104

SPAT

Monitoring of emergency patient

1.8

6.7

114

655

J01CA08

ATC

pivmecillinam; oral

1.2

6.6

1364

12181

CKC15

NOMESCO Finland

Panretinal photocoagulation

4.2

6.6

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

5.9

6.6

E26.0

ICD-10 Finland

Primary hyperaldosteronism

5.9

6.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.2

6.6

1387

12420

P01AB01

ATC

metronidazole; oral, rectal

1.2

6.6

1163

10226

O44.1

ICD-10 Finland

Placenta praevia with haemorrhage

2.8

6.5

141

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.5

1982

18425

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

4.3

6.5

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

6.5

510

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

6.5

118

692

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

6.5

209

1420

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.6

6.5

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

6.5

156

992

O28.1

ICD-10 Finland

Abnormal biochemical finding on antenatal screening of mother

2.9

6.4

129

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.4

390

2992

M04AA01

ATC

allopurinol; systemic

2.0

6.4

421

WW200

SPAT

1.4

6.4

279

2021

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.3

6.3

418

3243

SPAT1281

SPAT

Other administrative function

1.6

6.3

161

1037

O28.0

ICD-10 Finland

Abnormal haematological finding on antenatal screening of mother

8.2

6.3

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.4

6.3

306

2259

ZX120

NOMESCO Finland

Intravenous

1.5

6.3

180

1192

R06.0

ICD-10 Finland

Dyspnoea

1.3

6.2

430

3357

127

Kela drug reimbursment

Transplant complication

3.1

6.2

100

W90

ICPC

Uncompl labour/delivery livebirth

1.6

6.2

154

986

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.7

6.2

140

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

6.2

294

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

6.2

403

3119

SPAT1190

SPAT

Insertion or removal of intrauterine contraceptive device

1.4

6.2

260

1868

O45.9

ICD-10 Finland

Premature separation of placenta, unspecified

3.9

6.2

I50.9

ICD-10 Finland

Heart failure, unspecified

2.3

6.1

242

H3600, E113

ICD-10 Finland

5.7

6.1

C02CA01

ATC

prazosin; oral

7.7

6.1

R03BA02

ATC

budesonide; inhalant

1.3

6.1

446

3513

MA2JE

NOMESCO Finland

Ultrasound screening of fetal nuchal translucency

1.4

6.1

343

2595

C09BB04

ATC

perindopril and amlodipine; systemic

3.7

6.1

Z32.0

ICD-10 Finland

Pregnancy, not (yet) confirmed

1.7

6.1

107

624

MBA30

NOMESCO Finland

Manual removal of placenta from delivered uterus

1.9

6.0

407

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

6.0

2067

19367

C02DE10

ATC

10.0

6.0

R04.0

ICD-10 Finland

Epistaxis

2.0

6.0

382

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.6

6.0

162

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3020682) Albumin/Creatinine [Ratio] in Urine

1215

4525

3.70

263.45

4.7

3.6

mg/mmol

12.7

5.9

4.05

835

2719

(3012516) Albumin [Mass/volume] in Urine

1183

4342

3.72

262.07

3.9

3.0

mg/l

117.6

534.1

4.09

823

2513

(3009508) Creatinine [Moles/volume] in Urine

1256

5350

3.20

211.04

3.8

3.0

mmol/l

7.7

7.5

0.94

1134

4652

(3026493) Urate [Moles/volume] in Serum or Plasma

1042

5773

2.19

86.28

2.8

1.9

umol/l

1139.7

2309.7

1.09

964

5192

(3044889) 12 lead EKG panel

2238

16740

2.09

79.10

3.2

2.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3053

26764

3.45

64.46

14.0

9.1

mmol/l

3.9

0.16

3009

26048

(3019550) Sodium [Moles/volume] in Serum or Plasma

3040

26662

3.28

62.55

13.8

9.1

mmol/l

139.4

139.7

8.76

2998

26036

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2743

23203

2.19

56.18

6.4

3.9

mmol/mol

40.5

37.3

47.32

2640

22145

(3011985) Renin [Units/volume] in Plasma

132

309

4.41

51.69

1.7

1.8

mu/l

104.9

46.0

1.28

120

286

(3013826) Glucose [Moles/volume] in Serum or Plasma

1726

12900

1.72

49.03

5.4

3.7

mmol/l

6.9

6.2

20.64

1587

11790

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

367

1629

2.41

49.02

3.4

4.2

u/l

216.1

235.0

2.22

349

1552

(3003458) Phosphate [Moles/volume] in Serum or Plasma

448

2206

2.20

46.75

7.5

4.8

mmol/l

1.0

0.56

427

2083

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

165

498

3.44

45.12

2.8

1.7

g/l

1.3

1.5

2.12

144

422

(3024561) Albumin [Mass/volume] in Serum or Plasma

1295

9148

1.69

43.64

5.5

4.0

g/l

36.4

37.1

5.89

1231

8604

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

118

289

4.20

43.56

1.5

pmol/l

504.4

321.2

0.86

226

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

273

1154

2.49

40.33

1.8

—

(3029937) Albumin [Presence] in Urine by Test strip

998

6704

1.71

39.70

4.6

3.3

estimate

0.0

1.68

359

2492

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

656

3940

1.83

38.30

2.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2861

25628

2.00

34.89

4.5

3.4

mmol/l

6.0

5.6

34.52

2729

24359

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

230

962

2.50

34.66

1.5

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

104

280

3.80

33.73

2.5

2.7

ug/min

168.7

61.0

0.78

183

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1389

10457

1.57

33.45

7.6

5.2

mmol/l

1.2

1.56

1177

8875

(3012095) Magnesium [Moles/volume] in Serum or Plasma

527

3097

1.84

32.52

3.1

3.2

mmol/l

0.8

0.23

495

2914

(3018418) pH of Serum or Plasma

909

6218

1.64

32.48

4.6

3.4

7.4

0.53

177

1206

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1249

9224

1.58

32.40

6.9

4.6

mmol/l

1.2

2.99

1164

8520

(3035350) Ketones [Presence] in Urine by Test strip

1650

12990

1.55

32.10

4.0

3.1

estimate

0.0

0.09

361

2420

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2986

27328

2.19

31.83

5.0

3.7

mmol/l

2.9

3.0

6.13

2861

26111

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

287

1371

2.20

31.81

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

1664

13170

1.54

31.28

4.0

3.1

estimate

0.0

0.21

362

2474

(3021601) Nitrite [Presence] in Urine by Test strip

1649

13067

1.53

30.53

5.2

4.2

estimate

0.0

1.34

375

2518

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1354

10323

1.54

29.69

4.2

3.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2956

27127

2.03

28.48

4.6

3.5

mmol/l

4.8

5.0

22.41

2851

26098

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2864

26042

1.86

27.90

4.1

3.1

mmol/l

1.4

1.2

40.36

2751

24968

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2230

19133

1.53

26.51

7.4

6.6

u/l

75.2

72.1

4.58

2135

18154

(3019150) Specific gravity of Urine by Refractometry

789

5436

1.60

26.48

4.3

3.3

kg/l

1.0

0.56

107

770

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2938

27024

1.94

26.31

4.5

3.4

mmol/l

1.4

1.6

98.27

2824

25952

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

154

4.35

26.01

1.5

1.4

nmol/l

1.7

1.4

1.20

140

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

482

2949

1.75

25.50

1.5

—

(3032080) INR in Blood by Coagulation assay

960

6971

1.54

25.37

5.6

4.7

inr

1.1

0.15

352

2353

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

542

3440

1.69

25.06

2.4

ng/l

942.9

434.1

0.99

455

2786

(3026008) Bacteria identified in Urine by Culture

910

6607

1.52

23.77

2.7

2.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1515

12194

1.46

23.52

5.2

5.3

umol/l

9.3

9.4

0.09

1438

11545

(3000850) Epithelial cells [#/volume] in Urine

655

4428

1.60

23.43

3.2

2.2

e6/l

8.4

8.3

0.01

585

3845

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

971

7189

1.50

22.94

2.8

2.4

ng/l

24.1

24.4

0.02

451

2835

(3014576) Chloride [Moles/volume] in Serum or Plasma

332

1873

1.86

22.92

8.1

6.5

mmol/l

103.8

104.9

3.48

323

1838

(3017817) Protein [Mass] in Urine collected for unspecified duration

102

4.86

22.23

6.4

2.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3098

29283

2.33

22.14

11.2

8.4

u/l

27.7

24.0

14.16

3059

28603

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

328

3.02

22.04

1.2

nmol/l

—

0.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

324

2.99

21.28

1.2

nmol/l

0.5

0.72

318

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

125

494

2.59

21.19

3.8

2.9

mg/l

1.5

1.2

2.94

118

468

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

109

403

2.76

21.07

1.2

1.1

iu/ml

14.3

24337.5

0.64

110

(3016502) Oxygen saturation in Arterial blood

256

1372

1.94

20.62

8.7

7.9

96.2

96.6

0.31

248

1320

(3002173) Hemoglobin [Mass/volume] in Arterial blood

249

1327

1.95

20.39

8.9

8.1

g/l

122.6

122.1

0.12

241

1277

(3000991) Gas panel - Venous blood

229

1186

2.00

20.36

10.3

7.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

849

6248

1.49

20.19

1.7

1.6

mmol/l

1.5

1.4

6.37

725

5521

(3037467) Urinalysis macro (dipstick) panel - Urine

2092

18151

1.43

20.04

4.8

3.7

—

(40761535) Cells panel - Urine sediment

286

1609

1.85

19.85

4.2

3.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

181

870

2.14

19.66

9.0

7.2

mmol/l

24.5

24.4

0.13

169

810

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

287

1626

1.84

19.47

8.3

7.1

kpa

5.1

5.0

0.38

277

1563

(3027801) Oxygen [Partial pressure] in Arterial blood

287

1626

1.84

19.47

8.3

7.1

kpa

13.5

13.9

0.53

277

1563

(3003396) Base excess in Arterial blood by calculation

286

1623

1.84

19.29

8.4

7.2

mmol/l

1.1

0.9

0.43

224

1239

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

868

6466

1.47

19.25

1.9

1.7

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

975

7428

1.45

19.21

3.3

2.3

u/l

55.1

56.8

0.14

914

6944

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

292

2.96

18.83

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

842

6287

1.46

18.29

2.2

1.7

mg/l

0.8

0.7

0.64

658

4641

(3007853) Bacteria identified in Skin by Aerobe culture

432

2794

1.63

18.16

1.7

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2758

25421

1.57

18.14

10.7

8.2

ml/min/173m2

91.0

91.4

0.54

2347

21008

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2866

26665

1.65

18.06

5.9

5.0

mu/l

1.7

1.9

1.39

2755

25536

(3036481) Cortisol [Moles/volume] in Serum or Plasma

423

2726

1.63

18.04

2.1

2.2

nmol/l

356.1

371.0

0.86

396

2538

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1172

9322

1.40

17.84

3.3

3.0

u/l

29.2

28.6

0.23

1115

8950

(3031040) Bacteria [#/volume] in Urine by Automated count

1979

17212

1.39

17.27

4.9

3.5

e6/l

844.1

1391.7

0.32

167

(3019060) Gas panel - Arterial blood

173

860

2.07

17.22

6.8

5.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

765

5668

1.46

17.13

4.1

3.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

159

3.50

16.20

2.1

1.7

nmol/l

1.6

3.8

0.82

123

(3020891) Body temperature

121

541

2.28

15.73

5.8

4.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

102

423

2.46

15.71

4.5

2.6

nmol/l

1.0

0.8

2.10

374

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1478

12408

1.35

15.37

4.4

3.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

147

718

2.10

15.35

4.0

2.3

g/l

4.0

3.5

3.79

137

676

(3018677) aPTT in Platelet poor plasma by Coagulation assay

406

2694

1.58

15.21

2.2

2.0

28.8

29.1

0.53

391

2607

(3037121) Protein [Mass/volume] in Urine

128

602

2.17

14.74

3.6

3.2

g/l

0.5

0.3

1.29

207

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

244

1436

1.76

14.53

5.2

3.1

ng/l

95.5

72.5

3.61

223

1303

(3021447) Carbon dioxide [Partial pressure] in Venous blood

220

1257

1.80

14.48

6.7

3.3

kpa

5.8

0.01

211

1218

(3019832) Treponema pallidum Ab [Presence] in Serum

657

4863

1.44

14.48

1.7

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2584

23781

1.43

14.36

5.1

4.4

pmol/l

14.5

14.2

6.35

2469

22647

(3002582) Erythrocytes [#/volume] in Urine

830

6415

1.40

14.29

3.8

2.6

e6/l

46.7

96.6

1.13

661

4799

(3002032) Base excess in Venous blood by calculation

218

1248

1.80

14.26

6.7

3.3

mmol/l

1.8

0.01

180

1016

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

109

493

2.25

13.83

2.9

2.1

—

(3021589) Normoblasts [#/volume] in Blood

1397

11751

1.33

13.82

8.5

7.8

e9/l

0.0

0.05

1158

9647

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

288

2.64

13.58

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

105

472

2.27

13.52

4.6

4.0

mmol/l

1.3

0.38

105

463

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

375

2513

1.56

13.39

2.5

2.0

u/l

7429.4

4933.7

1.02

185

973

(3015377) Calcium [Moles/volume] in Serum or Plasma

964

7716

1.36

13.15

3.3

3.1

mmol/l

2.3

0.23

908

7066

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

774

5984

1.39

13.13

2.5

2.1

mg/l

3.0

2.7

4.56

695

5188

(3034274) Bile acid [Moles/volume] in Serum --fasting

127

624

2.08

13.10

2.5

2.3

umol/l

4.1

5.6

1.39

463

(3026782) Osmolality of Urine

551

4017

1.45

13.04

3.1

2.4

mosm/kgh2o

514.2

520.6

0.26

484

3416

(3018095) Leukocytes [#/volume] in Urine

1008

8152

1.34

12.77

4.3

3.0

e6/l

54.0

67.1

0.48

727

5339

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

767

5953

1.38

12.64

2.0

1.9

u/l

118.8

139.0

0.67

728

5691

(3044640) Blood type and Crossmatch panel - Blood

980

7904

1.34

12.61

2.2

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

9.41

12.55

6.3

6.9

—

(36304419) Bacteria [Presence] in Urine

760

5899

1.38

12.50

3.3

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

296

1910

1.61

12.41

2.9

2.2

ml/min/173m2

68.7

79.7

4.61

130

716

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

146

769

1.94

12.41

10.6

9.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

158

856

1.89

12.34

8.9

1.3

1.4

0.68

158

850

(40761511) CBC panel - Blood by Automated count

3082

29631

1.83

12.33

12.9

9.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

958

7737

1.34

12.12

3.5

2.6

—

(3030467) Casts [#/volume] in Urine by Automated count

748

5826

1.37

11.97

3.5

2.5

e6/l

0.2

0.3

0.73

580

4262

(3042936) Bacteria identified in Isolate by Culture

422

2968

1.49

11.96

2.0

1.8

—

(3024354) Oxygen [Partial pressure] in Venous blood

177

1004

1.81

11.96

6.0

2.7

kpa

4.8

4.7

0.11

167

970

(3014111) Lactate [Moles/volume] in Serum or Plasma

215

1292

1.71

11.89

9.0

6.4

mmol/l

1.2

0.30

207

1252

(3050129) First trimester maternal screen panel - Serum or Plasma

302

1989

1.57

11.60

1.5

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

176

1007

1.79

11.56

2.2

1.8

ug/l

3.5

5.2

1.67

150

885

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

399

2795

1.49

11.52

3.1

2.2

23.4

24.2

0.52

344

2419

(3004789) Transferrin [Mass/volume] in Serum or Plasma

439

3138

1.46

11.43

3.0

2.1

g/l

2.5

0.04

411

2915

(40761536) Microorganisms panel - Urine sediment

333

2250

1.54

11.41

4.1

3.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1747

15396

1.29

11.39

8.1

8.7

e9/l

4.3

3.9

13.40

1561

13675

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

155

862

1.84

11.18

9.1

8.9

0.7

0.23

155

857

(3043409) Potassium [Moles/volume] in Arterial blood

408

2.21

11.00

5.2

4.2

mmol/l

3.8

3.7

0.27

384

(3002385) Erythrocyte distribution width [Ratio]

2602

24269

1.37

10.96

15.1

11.9

13.5

0.22

2557

23852

(3027945) Reticulocytes/100 erythrocytes in Blood

255

1638

1.60

10.89

3.2

2.5

1.8

1.7

1.16

240

1450

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

127

669

1.94

10.83

7.6

3.6

mmol/l

24.0

24.3

0.60

105

607

(3022948) Iron [Moles/volume] in Serum or Plasma

478

3508

1.43

10.77

3.0

2.2

umol/l

13.6

14.6

2.62

451

3269

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

118

609

1.97

10.68

6.9

2.6

0.6

0.7

0.38

112

585

(3023368) Bacteria identified in Blood by Culture

584

4452

1.38

10.53

3.7

3.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

599

4599

1.37

10.31

1.8

1.5

pmol/l

51504194.5

35380904.1

0.25

532

4087

(3033658) Prothrombin time (PT) actual/Normal

751

5982

1.33

10.14

3.6

3.2

100.8

99.7

0.65

727

5791

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

467

3459

1.41

9.95

2.9

2.8

ng/l

377.7

298.0

0.18

278

1716

(4034850)

148

846

1.79

9.79

8.1

6.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

105

540

1.98

9.64

1.6

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

331

2323

1.47

9.42

7.1

4.4

—

(40768446) Kidney Pathology biopsy report

3.96

9.31

1.8

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

311

2172

1.48

9.07

1.5

—

(3047181) Lactate [Moles/volume] in Blood

103

538

1.94

9.06

7.6

5.8

mmol/l

1.3

1.2

0.36

476

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

386

2809

1.42

9.06

2.2

2.4

umol/l

5.8

5.7

0.04

320

2364

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

412

2.07

8.82

1.6

1.5

mmol/l

8.4

7.6

1.33

254

(3019309) Folate [Moles/volume] in Red Blood Cells

415

3082

1.40

8.66

1.9

1.7

nmol/l

1305.1

1174.1

2.41

353

2484

(3039000) Anion gap in Blood

342

2.16

8.63

9.8

7.4

mmol/l

11.4

11.1

0.43

309

(3018572) Chloride [Moles/volume] in Blood

343

2.15

8.57

9.8

7.4

mmol/l

105.9

105.4

0.57

310

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2901

27777

1.43

8.56

12.9

9.9

mg/l

17.2

17.9

0.69

2456

21182

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1704

15299

1.24

8.23

3.5

2.9

ug/l

71.6

69.5

0.36

1637

14632

(3001604) Monocytes [#/volume] in Blood

1524

13522

1.24

8.20

6.0

5.8

e9/l

0.5

5.19

1358

12050

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

473

3620

1.36

8.19

2.2

2.4

mmol/l

2.4

1.19

419

3178

(40760892) CBC W Ordered Manual Differential panel - Blood

852

7080

1.28

8.12

4.4

4.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

338

2.13

8.09

1.5

1.4

—

(3016750) Collection duration of Urine

3.44

7.94

2.3

2.5

min

504.8

501.5

0.07

(3006315) Basophils [#/volume] in Blood

1525

13567

1.23

7.89

6.0

5.8

e9/l

0.0

1.83

1358

12052

(3019198) Lymphocytes [#/volume] in Blood

1569

14015

1.23

7.77

6.0

5.8

e9/l

2.0

0.94

1435

12724

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1323

11608

1.24

7.75

2.8

2.2

nmol/l

72.2

74.9

3.74

1270

10963

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

242

1668

1.49

7.55

3.5

3.0

mmol/l

1.2

1.36

212

1466

(3036489) Thrombin time

157

982

1.63

7.54

2.1

1.9

20.3

20.4

0.11

125

804

(3004775) Volume in Urine collected for unspecified duration

3.14

7.40

2.4

2.5

652.9

609.3

0.13

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

994

8491

1.25

7.35

2.0

1.7

pmol/l

98.7

100.7

0.70

574

4586

(3015235) Bicarbonate [Moles/volume] in Capillary blood

379

2.00

7.32

3.1

2.5

mmol/l

24.0

24.3

0.20

338

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

345

2.05

7.32

4.1

3.5

u/ml

0.3

0.4

0.51

192

(3009343) pH of Capillary blood

150

938

1.63

7.22

3.3

2.5

7.4

0.67

138

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

509

1.85

7.18

1.7

1.3

u/ml

97.9

110.6

0.79

130

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

102

576

1.80

7.12

5.0

3.3

56.0

49.6

1.72

102

570

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

140

868

1.64

6.98

2.3

1.9

98.1

97.7

0.09

129

796

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

150

950

1.61

6.87

3.3

2.5

kpa

5.1

0.28

143

887

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

144

903

1.62

6.87

3.2

2.4

mmol/l

1.2

1.4

0.14

100

641

(3013115) Eosinophils [#/volume] in Blood

1566

14100

1.21

6.81

6.0

e9/l

0.2

4.53

1427

12778

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

528

1.80

6.70

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

101

581

1.76

6.65

8.0

5.1

1.9

1.8

0.44

543

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

154

992

1.58

6.59

2.2

2.5

ng/l

96.3

80.0

0.21

134

887

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

438

3424

1.32

6.52

2.7

2.2

e6/l

1.0

1.2

0.39

256

1840

(3003338) MCHC [Mass/volume]

2674

25493

1.28

6.50

17.0

12.4

g/l

331.8

331.6

0.38

2664

25328

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

529

1.78

6.38

1.5

1.4

mmol/l

7.0

0.02

387

(3006653) Thiamine [Moles/volume] in Blood

136

2.59

6.36

2.0

1.6

nmol/l

135.8

125.9

0.58

136

(3007461) Platelets [#/volume] in Blood

3190

31383

2.09

6.36

20.1

14.8

e9/l

279.7

272.0

10.12

3165

30883

(3024928) Oxygen saturation in Venous blood

295

2.05

6.36

10.1

3.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

700

5832

1.26

6.32

2.1

1.9

—

(3042733) HLA Ab [Presence] in Serum

3.59

6.31

5.1

4.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

256

1849

1.42

6.27

2.4

2.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

155

1013

1.56

6.24

4.4

2.3

e6/l

0.2

0.11

144

959

(3010813) Leukocytes [#/volume] in Blood

3192

31420

2.10

6.19

20.1

14.8

e9/l

7.1

6.6

32.29

3160

30874

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

333

1.97

6.16

1.4

1.3

—

31.7

—

(3024731) MCV [Entitic volume]

3191

31408

2.08

6.16

20.0

14.7

89.4

90.3

31.72

3181

31174

(3035941) MCH [Entitic mass]

3191

31409

2.08

6.14

20.0

14.7

29.7

30.1

19.78

3182

31172

(3000963) Hemoglobin [Mass/volume] in Blood

3192

31427

2.08

6.07

20.2

14.8

g/l

134.8

133.8

5.33

3182

31187

(3026361) Erythrocytes [#/volume] in Blood

3191

31414

2.07

6.06

20.1

14.8

e12/l

4.6

4.5

28.69

3160

30887

(1616796) Gas panel - Central venous blood

378

1.90

6.03

2.6

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

581

4775

1.26

5.86

1.4

titre

572.5

591.0

0.07

112

982

(3007930) Methemoglobin/Hemoglobin.total in Blood

582

1.71

5.81

8.2

5.2

1.0

0.9

0.23

545

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

150

993

1.54

5.73

1.9

2.0

g/l

0.2

1.38

143

937

(40758558) Short blood count panel - Blood

779

6633

1.23

5.70

6.0

6.6

—

(3010421) pH of Blood

451

1.79

5.69

2.4

2.6

7.4

0.50

374

(3013707) Erythrocyte sedimentation rate by Westergren method

2164

20268

1.20

5.67

4.3

3.8

mm/h

11.6

9.4

16.19

2070

19272

(3006184) Hemoglobin [Mass/volume] in Capillary blood

395

1.84

5.60

2.1

1.8

g/l

131.0

132.7

0.30

293

(3007566) Smooth muscle Ab [Titer] in Serum

119

751

1.61

5.60

1.2

1.3

titre

67.5

194.2

1.04

(46235355) HIV 1 and 2 tests - Meaningful Use set

901

7800

1.21

5.58

2.0

1.9

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

292

1.97

5.45

1.3

mmol/l

10.8

12.2

0.52

(3021901) Oxygen saturation in Capillary blood

258

2.03

5.43

2.9

2.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

527

4324

1.26

5.36

1.6

1.4

nmol/l

20.3

20.8

0.38

485

3888

(3023520) Reticulocytes [#/volume] in Blood

159

1085

1.49

5.29

2.3

2.5

e9/l

83.1

71.9

2.85

129

775

(3012501) Base excess in Blood by calculation

377

1.82

5.14

2.5

2.6

mmol/l

2.4

2.2

0.20

238

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

145

977

1.51

5.14

2.1

iu/l

3.2

4.3

1.28

430

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

121

2.49

5.12

1.1

1.4

—

(3019230) Fractional oxyhemoglobin in Venous blood

232

2.04

5.00

11.1

2.7

63.8

63.0

0.09

232

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

311

3970

0.76

4.97

1.8

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

923

8091

1.20

4.90

1.7

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

323

2521

1.31

4.86

3.4

pmol/l

4.6

4.5

0.76

304

2266

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

123

811

1.54

4.84

2.5

2.2

182.6

160.7

1.87

113

768

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

149

1025

1.48

4.79

1.9

2.0

g/l

1.3

1.2

3.96

142

968

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

119

2.45

4.79

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

250

1.97

4.78

1.3

1.5

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.58

4.76

1.0

1.1

umol/24h

0.5

0.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

239

1798

1.36

4.64

1.4

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

324

1.84

4.64

2.0

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

135

2.31

4.52

1.1

1.3

u/l

327.9

295.8

0.08

124

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

402

1.73

4.47

2.4

2.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

391

3165

1.27

4.45

1.2

iu/ml

200.8

152.3

0.70

164

1321

(3024471) HLA-A [Type]

2.93

4.44

1.1

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

186

1354

1.40

4.43

1.5

1.6

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

240

1825

1.34

4.35

2.6

2.2

g/l

0.2

0.11

233

1732

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

241

1834

1.34

4.35

1.5

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

398

1.72

4.34

1.5

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

213

2812

0.74

4.32

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

119

2.36

4.32

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

198

1465

1.37

4.28

1.3

u/ml

0.3

1.1

1.95

123

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.51

4.21

1.0

1.1

—

(3022313) Gas panel - Capillary blood

645

1.55

4.16

3.5

2.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

353

2846

1.27

4.15

1.6

1.7

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

351

1.75

4.15

1.3

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

135

2.23

4.08

3.1

2.9

mg/l

8.1

7.3

0.30

104

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

104

2.41

4.05

1.0

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

182

1343

1.38

4.02

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

196

2.00

4.02

1.2

—

(1002224) Polysomnography panel

210

1587

1.35

3.99

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

1.90

3.82

1.3

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

233

1803

1.31

3.78

15.9

9.2

inr

1.1

0.11

325

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

187

1.99

3.77

1.8

1.6

43.1

38.5

0.25

105

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

174

2.02

3.74

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

216

1.91

3.72

1.7

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

115

2.27

3.70

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

148

2.11

3.68

3.3

3.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

261

1.81

3.64

1.2

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

129

2.18

3.63

2.1

2.3

au/ml

165.9

155.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

247

1.83

3.62

1.2

1.1

ratio

1.0

0.64

(4306422)

538

1.56

3.61

1.1

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

367

1.67

3.59

1.2

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

711

6242

1.18

3.57

1.3

iu/ml

21.2

25.7

0.45

238

1985

(4146454)

117

2.23

3.57

3.0

2.7

—

(3003694) ABO and Rh group [Type] in Blood

928

8322

1.16

3.56

1.9

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

477

1.59

3.55

2.6

2.0

ug/l

2.6

2.0

0.20

429

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

686

6020

1.18

3.46

1.3

u/ml

4.9

9.0

3.01

333

2674

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

230

0.30

3.43

4.1

12.1

nmol/l

525.7

888.1

—

223

(3021440) Promyelocytes/100 leukocytes in Blood

241

1907

1.28

3.34

4.3

0.1

0.2

0.89

409

(3024932) HLA-DR beta [Type]

2.62

3.30

1.1

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

232

1832

1.29

3.27

4.3

4.0

0.4

0.6

1.03

331

(3009214) Lutropin [Units/volume] in Serum or Plasma

148

1096

1.37

3.26

1.2

u/l

11.1

13.6

1.31

125

902

(3017181) Myelocytes/100 leukocytes in Blood

249

1986

1.27

3.24

4.4

4.2

0.7

1.0

0.73

442

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

537

1.52

3.22

1.5

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

2.67

3.22

2.0

1.9

ug/min

13.2

146.9

—

(3052851) Hemolysis interference index of Serum or Plasma

635

1.48

3.22

2.3

2.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

318

1.68

3.18

1.3

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

207

1.85

3.16

1.2

1.3

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

7.51

3.05

1.2

1.3

kpa

2.7

4.8

—

(3006598) pH of Arterial cord blood

7.51

3.05

1.2

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

7.51

3.05

1.2

1.3

kpa

6.7

7.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

155

1172

1.34

3.01

2.9

2.1

u/l

37.9

39.8

0.59

141

1100

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

612

1.47

2.99

1.3

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

155

1.94

2.94

1.1

—

(3025159) Blasts/100 leukocytes in Blood

229

1832

1.27

2.93

4.5

4.3

0.0

0.3

0.54

348

(3003181) Sodium [Moles/volume] in Urine

213

1.79

2.91

1.7

1.5

mmol/l

74.3

67.3

0.33

177

(40767503) Oxygen content in Capillary blood by calculation

343

1.61

2.88

2.6

1.9

16.7

17.2

0.53

172

(1761868) Lipid panel - Serum or Plasma

1313

12195

1.13

2.88

2.7

2.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

102

2.16

2.86

15.5

25.4

ug/l

86.0

106.2

1.53

(3006504) Eosinophils/100 leukocytes in Blood

1361

12672

1.13

2.86

6.2

5.8

2.8

0.47

1282

11896

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

520

1.49

2.85

1.1

126.0

119.0

1.19

478

(3017446) Testosterone [Moles/volume] in Serum or Plasma

393

1.56

2.80

1.3

nmol/l

1.0

1.2

0.81

322

(3019069) Monocytes/100 leukocytes in Blood

1367

12744

1.13

2.79

6.3

6.0

7.7

7.9

1.20

1302

12073

(3010144) Erythrocytes [#/volume] in Synovial fluid

173

1.86

2.76

1.4

e6/l

2995.3

67214.0

1.01

122

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

248

1.70

2.72

1.2

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

118

2.04

2.71

1.0

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

466

4047

1.18

2.65

1.8

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

140

1.94

2.65

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.66

2.62

1.3

1.2

—

(3004451) EKG impression Narrative

2.66

2.62

1.1

—

(4010399)

205

1643

1.26

2.62

1.3

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

141

1076

1.32

2.61

2.0

2.1

—

(3011648) Oxygen content in Venous blood

113

2.04

2.61

3.0

2.3

10.8

11.3

0.25

113

(3022096) Basophils/100 leukocytes in Blood

1308

12201

1.12

2.59

6.3

5.9

0.7

0.61

1230

11453

(3028026) IgM [Mass/volume] in Serum or Plasma

195

1559

1.27

2.55

1.6

1.9

g/l

1.3

1.4

0.69

181

1462

(3027305) Fractional oxyhemoglobin in Arterial cord blood

7.15

2.55

1.0

1.3

46.0

30.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

575

1.44

2.54

1.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.61

2.53

1.3

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

208

2554

0.80

2.48

4.4

3.2

29.8

32.6

4.10

181

1957

(21494890) Protein electrophoresis panel - 24 hour Urine

109

2.03

2.46

1.3

2.1

—

(3017704) Immunofixation for Urine

2.46

2.44

1.1

1.5

—

(40768793) Breast Pathology biopsy report

953

0.69

2.41

1.2

1.3

—

(3042631) Mycobacterium sp identified in Specimen

145

1.87

2.41

1.4

2.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

101

743

1.37

2.40

10.8

8.9

mmol/l

24.1

0.08

712

(3020093) Fractional oxyhemoglobin in Venous cord blood

6.26

2.37

1.4

1.3

75.7

66.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

419

1.49

2.34

10.4

5.6

iu/ml

694.8

329.8

0.38

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

379

1.51

2.33

1.6

1.2

—

52.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

1408

13253

1.11

2.29

6.2

5.8

28.8

30.0

5.24

1334

12514

(4094501)

530

1.42

2.27

1.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

390

1.50

2.26

2.5

2.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

464

1.45

2.25

4.1

3.0

mg/l

18.7

22.4

0.63

272

(3018010) Neutrophils/100 leukocytes in Blood

1390

13087

1.11

2.23

6.1

5.6

57.6

56.3

5.20

1319

12392

(3019174) dRVVT (LA screen)

3.11

2.22

1.1

—

(42870588) Differential panel, method unspecified - Blood

916

8434

1.12

2.22

5.9

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

5.56

2.21

1.0

—

(3022670) pH of Venous cord blood

5.56

2.21

1.4

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

584

1.40

2.20

3.5

2.4

mmol/l

24.6

24.7

0.18

542

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

369

3196

1.17

2.19

3.1

2.3

e6/l

5.4

4.5

0.58

188

1619

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.07

2.16

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.29

2.15

11.0

11.6

mmol/l

5.7

6.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

151

1202

1.27

2.10

2.3

2.2

g/l

65.9

67.8

2.37

144

1134

(3021387) Prolactin [Units/volume] in Serum or Plasma

224

1864

1.22

2.08

1.6

mu/l

278.7

311.7

1.29

198

1650

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

245

1.60

2.07

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

146

1.79

2.06

1.6

u/l

4.7

4.1

0.10

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.33

2.04

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.33

2.04

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.33

2.04

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.33

2.04

1.1

—

(3013512) EKG study

595

5365

1.13

2.03

2.9

2.5

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.82

2.00

1.0

1.1

—

3.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

133

1.81

1.99

1.3

1.0

106.5

97.3

1.06

(21494755) Public health laboratory ask at order entry panel

421

4754

0.87

1.98

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

597

1.37

1.96

1.6

1.8

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

134

1062

1.27

1.95

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.94

1.95

1.6

1.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

462

1.42

1.95

1.5

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

2.97

1.93

1.1

1.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.57

1.92

1.1

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.92

1.90

1.9

1.5

5.2

7.2

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

1.88

0.0

4.1

—

44.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.16

1.88

2.3

2.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

197

1.63

1.86

2.9

2.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

417

1.42

1.84

1.2

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

579

1.36

1.83

1.4

1.2

u/ml

234.8

263.4

0.44

395

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

545

1.37

1.82

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

724

0.70

1.78

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.76

1.77

1.2

1.0

116.3

100.2

1.65

(3003740) Influenza virus B Ag [Presence] in Specimen

723

0.70

1.77

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

154

1.69

1.76

1.3

1.1

g/l

0.3

0.70

127

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.44

1.75

1.0

1.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

818

7580

1.11

1.72

1.4

1.3

u/ml

1.3

1.4

0.34

298

2258

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.92

1.72

2.7

1.7

umol/24h

272.9

299.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

434

1.39

1.67

1.3

1.6

—

(3005719) IgG [Mass/volume] in Serum or Plasma

236

2021

1.18

1.66

2.5

2.6

g/l

10.8

10.4

1.04

223

1882

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.80

1.65

1.0

1.1

umol/24h

1.6

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

427

1.39

1.64

1.4

1.6

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.98

1.64

3.3

2.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

695

0.72

1.58

1.2

1.1

—

(3022621) pH of Urine by Test strip

192

1624

1.19

1.57

2.9

2.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

239

1.51

1.57

1.1

1.2

u/l

66.8

62.1

0.11

167

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.20

1.57

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

265

2304

1.16

1.56

2.8

2.2

u/l

31.5

37.0

1.07

220

1965

(3023323) Follitropin [Units/volume] in Serum or Plasma

444

4004

1.13

1.54

1.3

iu/l

24.5

30.6

4.43

394

3530

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

502

1.34

1.52

1.5

1.4

—

(3032057) Clostridioides difficile [Presence] in Stool

2.60

1.51

3.0

1.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

105

839

1.26

1.49

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

137

1128

1.22

1.49

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

162

1.61

1.49

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

162

1.61

1.49

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

162

1.61

1.49

1.3

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

279

2446

1.15

1.48

1.3

u/ml

145.4

186.8

0.43

259

2278

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.23

1.46

2.9

2.1

umol/l

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

310

1.43

1.45

4.1

2.7

umol/l

36.9

32.0

0.73

271

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.13

1.44

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

104

835

1.25

1.43

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

105

844

1.25

1.43

1.2

1.1

—

(44806071)

2.04

1.43

1.3

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

212

1.51

1.43

1.4

—

(3035933) Granulocytes/100 leukocytes in Blood

120

0.42

1.37

1.8

1.6

—

(3012898) Urea [Moles/volume] in Urine

2.61

1.36

1.7

mmol/l

191.3

187.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.61

1.36

2.0

2.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

460

1.33

1.36

1.8

1.7

e6/l

3205.7

7653.6

2.13

339

(40758292) HTLV I+II Ab panel - Serum

0.00

1.34

0.0

1.5

—

(3000494) Fungus identified in Specimen by Culture

325

2903

1.13

1.33

1.5

1.4

—

(3019225) pH of Specimen

164

1925

0.84

1.33

5.0

3.2

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

2.50

1.30

2.0

2.2

mg/l

30.7

21.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.05

1.26

1.1

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

146

1.58

1.25

2.7

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

278

1.41

1.24

1.1

—

(3025941) Bacteria identified in Stool by Culture

217

1897

1.15

1.24

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

278

0.61

1.24

1.5

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

131

1.61

1.23

1.2

1.5

u/field

6.0

2.3

0.30

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.77

1.23

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

155

1.55

1.22

1.3

1.8

u/field

2.5

1.9

0.28

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

277

0.61

1.22

1.5

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

277

0.61

1.22

1.5

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

288

1.39

1.21

1.4

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

194

1687

1.16

1.20

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

873

0.79

1.20

1.3

1.6

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

255

1.42

1.19

2.0

1.9

nmol/l

17.9

19.8

0.85

247

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.75

1.19

1.0

ug/l

70.6

74.1

0.17

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

109

1.66

1.18

1.1

2.0

ug/l

0.9

1.1

0.24

103

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

445

1.31

1.18

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

350

1.35

1.17

1.1

1.2

—

(40768797) Stomach Pathology biopsy report

390

3554

1.11

1.16

1.2

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

0.00

1.16

0.0

1.2

—

2.7

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

308

1.37

1.15

1.1

—

(3044941) Cell count panel - Synovial fluid

309

1.36

1.13

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.75

1.12

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

250

1.40

1.12

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

282

0.64

1.11

1.4

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

282

0.64

1.11

1.4

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

282

0.64

1.11

1.4

1.2

—

(3019977) pH of Arterial blood

1.78

1.10

1.6

4.2

7.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

638

1.24

1.09

1.4

e6/l

11023.2

1269.7

0.60

527

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

638

1.24

1.09

1.4

1.3

e6/l

21.1

21.6

0.02

500

(3010937) Rubella virus Ab [Presence] in Serum

2.19

1.08

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

192

1685

1.15

1.07

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

203

1789

1.14

1.07

1.4

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

111

933

1.20

1.05

1.6

2.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

203

1791

1.14

1.05

1.2

1.1

titre

399.3

164.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

111

1313

0.84

1.04

1.6

1.7

—

(3023419) Bacteria identified in Sputum by Culture

195

1.44

1.04

2.4

2.7

—

(3001556) Androgen free Index in Serum or Plasma

1.96

1.03

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.27

1.03

1.0

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

204

1.43

1.03

1.0

1.2

titre

88.6

168.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

192

1692

1.14

1.02

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

171

1.47

1.02

2.1

2.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

251

0.64

1.01

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

631

0.77

1.01

1.1

u/ml

1.7

3.6

2.00

357

(3025130) Human papilloma virus identified in Specimen

907

0.81

1.01

1.7

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

192

1694

1.14

1.00

1.4

—

(3020491) Glucose [Moles/volume] in Blood

180

1.45

1.00

3.2

1.4

mmol/l

7.1

6.1

0.68

134

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

248

1.37

0.99

1.4

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

136

1171

1.17

0.99

1.4

u/l

22.5

28.3

1.53

116

965

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.71

0.98

1.5

1.1

—

(3022689) Creatine [Moles/volume] in Urine

1.81

0.98

1.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

192

2166

0.88

0.98

1.2

1.3

au/ml

32.2

33.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.67

0.97

1.0

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

0.00

0.97

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

108

1.58

0.96

1.2

1.4

—

(3048689) Calprotectin [Mass/mass] in Stool

459

4261

1.09

0.96

2.7

2.3

ug/g

124.3

91.8

1.50

372

3331

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

532

1.25

0.96

1.3

1.2

u/ml

3.7

4.3

0.22

203

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.89

0.94

1.1

1.7

—

(3036071) Salmonella sp Ab [Titer] in Serum

120

0.50

0.93

1.0

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

243

1.36

0.92

2.0

1.6

41.5

50.3

0.52

142

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

226

1.38

0.92

6.5

7.2

—

(3017569) Oxygen content in Arterial blood

1.82

0.92

2.0

2.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

518

1.24

0.91

1.4

—

(4281824)

381

0.73

0.88

1.1

—

(3021788) Differential panel - Synovial fluid

361

1.28

0.85

1.5

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

112

964

1.17

0.85

1.6

iu/ml

0.0

19.3

0.51

174

(3028433) Virus identified in Specimen by Culture

1.67

0.85

1.4

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

263

0.68

0.85

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.63

0.84

2.7

3.0

ng/l

107.6

124.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.78

0.84

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

170

1909

0.88

0.84

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

248

1.33

0.83

1.7

3.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

250

0.68

0.83

1.1

1.3

—

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

336

1.28

0.83

1.6

3.3

mg/l

30.2

24.1

0.67

276

(3034860) Kappa light chains.free [Mass/volume] in Serum

336

1.28

0.83

1.6

3.3

mg/l

37.9

42.2

0.12

275

(40765089) Chromosome analysis panel - Blood by G-banded

111

0.54

0.83

1.2

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

112

0.53

0.83

1.7

1.1

—

(40768795) Lymph node Pathology biopsy report

238

0.67

0.83

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

212

2347

0.90

0.82

2.2

2.3

au/ml

18.6

23.6

—

211

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.81

1.2

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

232

1.34

0.81

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

1.48

0.80

1.8

1.7

—

(3008898) HLA-B27 [Presence]

186

1669

1.12

0.79

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

295

1.29

0.78

1.4

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

0.77

0.0

1.1

—

6.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

278

3023

0.91

0.77

1.4

1.6

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

466

1.23

0.77

1.7

2.1

g/l

0.2

0.5

0.52

430

(3035947) Staphylolysin Ab [Units/volume] in Serum

1.54

0.75

1.2

1.1

—

4.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

124

1.45

0.75

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.60

0.74

1.2

1.4

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

2.08

0.74

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

175

1.37

0.74

1.1

1.2

—

(44790048)

227

1.32

0.74

1.4

1.5

—

(44806118)

227

1.32

0.74

1.4

1.5

—

(44790047)

227

1.32

0.74

1.4

1.5

—

(44790049)

227

1.32

0.74

1.4

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

201

1.35

0.74

1.1

1.0

mg/l

289.6

299.4

0.41

182

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

121

1062

1.14

0.74

2.5

2.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

101

875

1.16

0.74

1.3

ug/l

4.1

3.3

0.30

778

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

289

1.28

0.74

1.3

1.2

u/ml

0.6

1.4

0.39

104

(3016650) Hepatitis A virus Ab [Presence] in Serum

460

1.22

0.73

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

150

1.40

0.73

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

322

0.74

0.72

1.0

u/ml

0.6

0.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

164

1824

0.89

0.72

1.8

1.7

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.55

0.71

1.2

1.3

—

(3006270) Folate [Moles/volume] in Blood

221

1.32

0.69

1.1

nmol/l

399.1

411.9

0.15

211

(3024891) Influenza virus A+B Ag [Presence] in Specimen

846

0.85

0.69

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

121

1068

1.14

0.69

1.3

1.4

nmol/l

0.3

0.5

3.70

841

(3015076) Soybean IgE Ab [Units/volume] in Serum

297

0.74

0.69

1.0

u/ml

0.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2100

20633

1.05

0.68

3.2

2.8

u/l

43.5

33.5

7.28

2012

19849

(4062490)

320

1.25

0.67

1.5

1.4

—

(40768441) Liver Pathology biopsy report

196

1.33

0.67

1.3

1.4

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

659

1.17

0.67

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

223

1.30

0.66

1.7

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.79

0.66

27.4

5.5

—

(3002256) Pathology report gross observation

345

3687

0.93

0.66

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

213

0.70

0.64

1.1

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

616

1.17

0.64

1.7

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

224

0.71

0.64

1.4

1.8

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

635

1.17

0.63

1.2

mmol/l

3.7

3.6

1.10

597

(3020191) Ethanol [Moles/volume] in Serum or Plasma

181

1.33

0.63

2.2

1.7

promille

1.4

1.3

0.07

140

(4198724)

153

0.65

0.62

2.5

3.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

553

1.18

0.62

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.55

0.62

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.67

0.61

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.67

0.61

27.4

5.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

931

8995

1.05

0.61

1.5

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.60

0.0

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.60

0.0

1.0

—

0.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.50

0.59

1.3

1.8

ug/l

9.3

7.8

0.52

(3037756) Immunofixation for Serum or Plasma

219

1.28

0.58

1.2

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

296

3163

0.93

0.58

1.7

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

125

1122

1.12

0.58

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

112

0.62

0.58

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

113

0.62

0.58

3.3

4.7

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.56

1.0

—

(44813793)

274

1.24

0.56

1.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

485

1.18

0.56

1.4

1.5

g/l

0.6

0.03

370

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

185

1.30

0.56

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

720

1.14

0.54

2.3

2.4

13.1

13.2

0.41

710

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

122

1352

0.90

0.54

2.4

1.9

—

(3035880) pH of Pleural fluid

1.58

0.54

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.58

0.54

1.0

1.3

—

(3020650) Glucose [Presence] in Urine

1.49

0.53

1.1

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

544

1.16

0.53

1.2

u/ml

2.9

2.8

0.03

180

(3013293) Extractable nuclear Ab [Presence] in Serum

1.45

0.53

1.4

1.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.45

0.53

1.6

1.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

507

4845

1.06

0.52

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

323

1.21

0.52

1.4

g/l

2.6

2.9

0.73

224

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.45

0.51

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

161

1.31

0.51

3.8

2.3

ug/l

26.7

184.9

0.67

152

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

188

1.28

0.51

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

109

1.38

0.51

1.3

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

109

1.38

0.51

1.3

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

109

1.38

0.51

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

109

1.38

0.51

1.3

1.8

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

324

1.21

0.50

1.4

g/l

6.5

6.2

0.26

226

(3024139) IgG subclass 3 [Mass/volume] in Serum

324

1.21

0.50

1.4

g/l

0.3

0.4

0.26

224

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

398

1.18

0.50

4.9

4.7

u/ml

111.6

102.1

0.05

130

(3044290) Cell count panel - Cerebral spinal fluid

604

1.15

0.49

1.3

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.43

0.49

2.0

2.2

umol/l

11.7

16.6

1.54

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

558

1.15

0.48

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

323

0.80

0.48

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

260

2440

1.07

0.48

3.1

2.6

u/ml

26.5

31.7

0.47

251

2370

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

181

1.27

0.48

1.2

1.1

nmol/l

21.0

5.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

852

1.12

0.47

2.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

166

0.72

0.47

1.1

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

373

1.18

0.47

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

373

1.18

0.47

1.1

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.41

0.46

1.3

1.1

115.8

111.3

0.17

(3006442) Creatine [Moles/volume] in Serum or Plasma

182

1.27

0.46

1.9

1.3

umol/l

62.1

62.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2466

24413

1.04

0.46

3.9

3.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

2.1

4.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

2.1

4.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.59

0.45

2.0

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.40

0.45

2.4

1.6

u/l

29.6

70.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

319

0.81

0.44

1.0

u/ml

0.6

2.2

0.64

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

111

1010

1.10

0.44

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

378

3962

0.95

0.44

1.6

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.37

0.43

1.0

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

583

6044

0.96

0.43

2.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

193

1.25

0.43

1.0

1.1

miu/ml

1547.3

1576.6

0.03

193

(3014271) Vancomycin [Susceptibility]

1.61

0.43

2.0

2.2

—

(3051651) Icteric interference index of Serum or Plasma

113

1.33

0.42

2.1

3.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.56

0.42

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

176

1.25

0.41

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

167

1.26

0.41

3.3

2.9

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

204

1.23

0.40

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

227

0.79

0.40

1.9

2.9

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.40

0.0

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(4024509)

193

0.78

0.39

2.0

1.4

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.39

0.0

1.2

—

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

204

0.78

0.39

1.6

1.3

—

(1175426) CD3 cells/100 lymphocytes in Blood

237

0.80

0.39

2.5

2.3

78.5

75.2

0.62

232

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

115

1.31

0.38

2.1

2.7

umol/l

90.5

201.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

114

1238

0.92

0.38

1.9

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.39

0.38

2.0

1.3

ng/l

227.6

73.9

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

402

3859

1.05

0.37

1.7

1.6

1.4

1.3

2.28

366

3490

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

1.13

0.37

1.6

1.9

g/l

3.0

0.09

413

(3013139) Helicobacter pylori Ag [Presence] in Stool

223

2107

1.06

0.37

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.31

0.37

1.0

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.31

0.37

1.0

1.3

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

716

1.11

0.36

1.1

1.0

u/ml

1.4

3.5

1.75

249

(3000012) Reticulocyte production index

1.36

0.36

1.2

1.3

—

(3028717) Thiamine [Mass/volume] in Blood

1.43

0.35

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

191

1.21

0.33

1.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

856

1.09

0.32

1.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

231

0.82

0.32

2.5

2.3

15.6

13.2

0.36

129

(3004716) Salmonella sp identified in Stool by Organism specific culture

191

2017

0.94

0.32

1.4

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

285

1.16

0.32

1.5

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

713

1.10

0.31

1.3

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

248

1.17

0.31

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.30

0.30

1.0

—

(4035726)

194

2042

0.95

0.30

1.4

1.3

—

(3027944) Amphetamines [Presence] in Urine

154

1632

0.94

0.30

1.4

2.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

100

1076

0.93

0.29

1.5

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

278

1.15

0.29

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

222

1.17

0.29

1.0

1.1

u/l

1.0

0.25

(3009542) Hematocrit [Volume Fraction] of Blood

2704

27188

0.97

0.29

13.4

10.6

40.2

39.7

2.84

2193

22910

(3049717) Cytology report of Urine Cyto stain

373

1.13

0.29

2.5

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

139

1.22

0.29

1.4

1.1

—

(3045424) Erythrocytes [Presence] in Urine

450

0.89

0.28

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

279

1.15

0.28

1.5

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

555

1.10

0.28

3.9

3.7

60.2

57.1

1.20

555

(3011412) CD3 cells [#/volume] in Blood

291

0.86

0.28

2.7

2.6

e9/l

1.3

1.4

0.12

178

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

158

1.20

0.28

1.2

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

365

0.88

0.28

1.2

1.3

nmol/l

29.8

32.5

0.18

324

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.29

0.28

5.6

3.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.30

0.28

1.4

1.9

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.30

0.28

1.4

1.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.30

0.28

1.4

1.9

—

(3045414) Leukocytes [Presence] in Urine

130

1224

1.06

0.27

1.8

1.7

—

(3034426) Prothrombin time (PT)

113

1.24

0.26

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

215

1.16

0.26

1.0

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

658

6431

1.03

0.26

1.4

g/l

2.2

2.1

1.66

433

4257

(1001926) Buprenorphine [Presence] in Urine by Screen method

116

1234

0.94

0.26

1.6

2.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

300

1.13

0.26

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

272

1.14

0.26

1.1

iu/ml

6.9

8.6

0.21

(3042111) Morphology [Interpretation] in Bone marrow Narrative

203

0.84

0.25

1.1

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

162

1540

1.05

0.25

2.3

1.7

mg/l

4.6

3.0

2.43

127

1053

(3033705) Calcium.ionized [Moles/volume] in Venous blood

138

0.80

0.25

1.8

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

540

1.09

0.25

1.6

1.9

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

540

1.09

0.25

1.6

1.9

g/l

3.7

0.08

396

(3025468) Yersinia sp identified in Specimen by Organism specific culture

273

1.14

0.25

1.5

—

(40768804) Tissue Pathology biopsy report

1235

12522

0.98

0.25

2.0

1.9

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

541

1.09

0.24

1.6

1.9

g/l

7.3

7.2

0.30

431

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

255

0.86

0.24

1.5

2.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

217

1.15

0.24

1.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

274

1.13

0.24

1.5

—

(3012441) Differential panel - Pleural fluid

0.71

0.24

2.3

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

1.32

0.23

1.0

1.8

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.6

2.2

mg/l

4.2

3.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

275

1.13

0.23

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.24

0.23

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

221

0.86

0.22

2.8

2.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.22

0.22

2.4

3.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

305

0.88

0.22

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.19

0.21

2.2

2.6

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.19

0.21

1.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.21

0.0

1.6

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

5.8

—

2.5

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.21

0.0

1.1

—

9.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.21

0.0

3.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

112

1061

1.06

0.21

1.1

u/ml

2.3

5.2

1.37

189

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

173

1804

0.96

0.21

2.9

3.7

ug/l

5.8

32.4

0.71

126

1284

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

104

0.77

0.21

3.0

2.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

105

0.76

0.21

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

96.9

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

38.0

—

(3004616) Nuclear Ab [Presence] in Serum

383

1.10

0.20

1.3

—

(40768443) Skin Pathology biopsy report

112

1063

1.06

0.20

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

139

1455

0.95

0.20

1.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.20

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.20

0.0

1.0

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

1.22

0.20

1.3

2.1

e6/l

295.2

7588.6

—

(3017509) Phencyclidine [Presence] in Urine

1.22

0.20

1.2

1.1

—

(4268621)

355

1.10

0.20

2.2

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

137

1.17

0.18

1.2

u/l

15.9

19.6

0.17

118

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

137

1.17

0.18

2.2

1.8

umol/l

27.0

30.3

1.24

130

(3023487) Leukocytes [#/volume] in Peritoneal fluid

1.13

0.18

1.3

2.2

e6/l

253.3

1203.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.13

0.18

1.0

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.13

0.18

1.0

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

579

1.07

0.18

1.1

1.0

u/ml

0.3

0.4

0.04

110

(36660697) Celiac disease serology panel - Serum

258

2657

0.97

0.18

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

522

5319

0.98

0.17

1.9

—

(3045142) Bone marrow Pathology biopsy report

163

0.86

0.17

1.1

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

101

1.19

0.16

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

215

1.12

0.16

1.1

1.2

—

53.2

—

(3000330) Specific gravity of Urine by Test strip

100

955

1.05

0.16

2.7

2.6

—

(3000764) Benzodiazepines [Presence] in Urine

158

1636

0.96

0.16

1.5

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

136

1412

0.96

0.15

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

0.78

0.15

3.5

2.3

—

(3024263) Appearance of Synovial fluid

102

1.18

0.15

1.2

2.3

—

(3027008) Opiates [Presence] in Urine

159

1644

0.97

0.15

1.4

1.8

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

140

1.14

0.15

1.2

u/l

88.3

78.0

0.17

122

(1761482) Bacteria [#/volume] in Urine by Culture

362

1.08

0.14

2.9

3.2

—

(40768806) Pleura Pathology biopsy report

0.79

0.14

3.0

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

285

0.91

0.14

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

139

0.86

0.14

3.3

2.7

47.7

46.1

—

(3028300) Cannabinoids [Presence] in Urine

160

1651

0.97

0.14

1.4

2.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.82

0.13

5.1

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.82

0.13

1.0

1.1

—

(3038026) Centromere Ab [Units/volume] in Serum

218

1.10

0.13

1.3

1.2

—

77.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

222

0.90

0.13

1.3

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

276

1.09

0.13

1.9

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

745

0.95

0.13

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

102

1060

0.96

0.13

1.2

1.3

u/ml

24.0

34.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

107

0.84

0.13

1.0

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

108

0.83

0.13

1.6

1.2

mmol/l

5.8

6.2

—

(3023410) Appearance of Cerebral spinal fluid

306

1.08

0.13

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

274

2685

1.02

0.12

1.5

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

807

1.04

0.11

1.2

1.1

u/ml

0.6

1.2

1.15

186

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

955

1.04

0.11

1.2

1.1

u/ml

0.9

1.0

0.05

341

(3017732) Neutrophils [#/volume] in Blood

222

2171

1.02

0.11

1.9

2.2

e9/l

4.6

4.0

2.27

198

1872

(3000570) Elastase.pancreatic [Mass/mass] in Stool

611

1.05

0.11

1.2

1.3

ug/g

276.1

317.5

0.74

290

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

562

1.05

0.11

4.0

3.4

u/ml

76.8

325.1

0.50

477

(3004809) Band form neutrophils/100 leukocytes in Blood

269

1.08

0.11

3.4

2.4

1.8

1.5

0.16

207

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

240

1.08

0.11

1.0

1.2

—

(3015183) Erythrocyte sedimentation rate

250

1.08

0.11

1.3

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.16

0.11

2.8

umol/l

29.2

28.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

136

0.88

0.11

2.3

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

672

1.04

0.10

1.1

u/ml

2.0

4.0

1.09

253

(4027681)

259

0.93

0.10

1.2

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.04

0.09

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

137

1404

0.97

0.09

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.82

0.08

2.0

2.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.82

0.08

1.2

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

0.83

0.08

1.6

1.5

—

(3036048) Francisella tularensis Ab [Titer] in Serum

0.81

0.08

1.0

1.1

—

224.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.05

0.07

1.4

2.6

—

(4211845)

143

0.91

0.07

2.5

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

883

0.97

0.07

1.2

1.3

u/ml

59.2

38.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.03

0.07

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

591

1.03

0.06

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

102

0.88

0.06

4.0

6.1

—

288.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

203

0.94

0.06

2.4

2.9

e6/l

983.9

857.1

—

(3014051) Protein [Presence] in Urine by Test strip

572

1.03

0.06

1.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

950

0.98

0.05

1.3

u/ml

22.9

8.5

0.44

168

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.11

0.05

1.5

1.2

108.4

97.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

218

1.06

0.05

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

704

1.02

0.04

1.6

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

764

1.02

0.04

2.0

1.9

—

(3000492) Spirometry study

286

2885

0.99

0.04

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

814

1.02

0.04

1.1

u/ml

0.3

1.1

2.39

318

(3022145) Colonoscopy Study observation

274

2764

0.99

0.04

1.4

1.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.10

0.04

1.5

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

362

0.97

0.04

1.1

—

121.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

935

0.98

0.03

1.3

u/ml

1.5

8.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

597

1.02

0.03

1.2

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

220

1.05

0.03

1.8

1.5

umol/l

20.8

25.5

0.40

209

(3016879) Cocaine [Presence] in Urine

147

1486

0.99

0.03

1.5

2.0

—

(21494434) Karyotype in Bone marrow

102

1.08

0.03

1.0

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

211

1.04

0.03

2.0

1.8

mg/l

24.1

21.8

0.14

(3017354) Segmented neutrophils/100 leukocytes in Blood

162

1.05

0.02

1.8

2.1

65.1

53.9

—

101

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

174

1751

0.99

0.01

1.4

1.3

miu/ml

220.0

237.3

0.28

900

(3006462) Nitrate [Presence] in Urine

127

0.94

0.01

2.7

2.2

—

(3009871) Measles virus Ab [Titer] in Serum

157

0.96

0.01

1.7

1.8

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

208

2070

1.01

0.01

1.6

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

858

0.99

0.01

1.2

1.1

u/ml

2.6

4.9

1.66

430

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

134

1.04

0.00

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

175

0.97

0.00

2.4

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

121

0.99

0.00

1.2

1.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

181

0.99

0.00

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

339

1.00

0.00

1.0

—

(3011288) Drugs identified in Urine by Screen method

112

1119

1.00

0.00

1.8

2.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

164

0.98

0.00

2.1

1.6

76.3

70.3

1.56

158

(3044927) Protein electrophoresis panel - Urine

1.02

0.00

1.2

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

1.01

0.00

1.1

—

(3047189) Immunofixation for 24 hour Urine

0.89

0.00

1.2

2.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.86

0.00

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.92

0.00

1.3

1.2

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.01

0.00

1.1

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

260

1.00

0.00

1.3

1.2

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

160

1.00

0.00

2.1

1.6

mu/l

453.8

423.9

0.11

154

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.95

0.00

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.93

0.00

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.97

0.00

1.2

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.98

0.00

1.2

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

7.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

194.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.90

0.00

2.9

3.4

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.0

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.97

0.00

1.0

—

(3045788) Cell count panel - Pleural fluid

0.92

0.00

2.6

1.4

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

0.93

0.00

1.3

—

(3033882) Carnitine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

35.5

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

5.2

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.3

—

178.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

111.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

250.4

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

-0.00

0.0

1.5

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint O15_EXIST_HYPERT_COMPLIC and mortality.

Females

Parameter	HR [95% CI]	p-value
O15_EXIST_HYPERT_COMPLIC	1.054 [0.89, 1.25]	0.548
Birth year	0.994 [0.99, 1.0]	0.175

During the follow-up period (1.1.1998 — 31.12.2019), 198 out of 14964 females with O15_EXIST_HYPERT_COMPLIC died.

Males

No data

Mortality risk

Mortality risk for people of age

years, who have O15_EXIST_HYPERT_COMPLIC.

N-year risk	Females	Males
1	0.086%	No data
5	0.485%	No data
10	1.409%	No data
15	2.639%	No data
20	4.928%	No data

Relationships between endpoints

↥

Index endpoint: O15_EXIST_HYPERT_COMPLIC – Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

GWS hits: 7

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints